<VariationArchive VariationID="126390" VariationName="NM_033629.6(TREX1):c.58dup (p.Glu20fs)" VariationType="Duplication" Accession="VCV000126390" Version="12" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2015-03-24" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="131923" VariationID="126390">
      <GeneList>
        <Gene Symbol="ATRIP" FullName="ATR interacting protein" GeneID="84126" HGNC_ID="HGNC:33499" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446737" stop="48467645" display_start="48446737" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48488113" stop="48507053" display_start="48488113" display_stop="48507053" Strand="+" />
          </Location>
          <OMIM>606605</OMIM>
        </Gene>
        <Gene Symbol="ATRIP-TREX1" FullName="ATRIP-TREX1 readthrough" GeneID="111822955" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446779" stop="48467645" display_start="48446779" display_stop="48467645" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TREX1" FullName="three prime repair exonuclease 1" GeneID="11277" HGNC_ID="HGNC:12269" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48465830" stop="48467645" display_start="48465830" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48506918" stop="48509043" display_start="48506918" display_stop="48509043" Strand="+" />
          </Location>
          <OMIM>606609</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033629.6(TREX1):c.58dup (p.Glu20fs)</Name>
      <CanonicalSPDI>NC_000003.12:48466711:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48466711" stop="48466712" display_start="48466711" display_stop="48466712" variantLength="1" positionVCF="48466711" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48508110" stop="48508111" display_start="48508110" display_stop="48508111" variantLength="1" positionVCF="48508110" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <OtherNameList>
        <Name>NM_033629.6(TREX1):c.58dup</Name>
        <Name>p.Glu20fs</Name>
      </OtherNameList>
      <ProteinChange>E20fs</ProteinChange>
      <ProteinChange>E10fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48508112dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48508112dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48466713dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48466713dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009820.2" sequenceAccession="NG_009820" sequenceVersion="2" change="g.5884dup">
            <Expression>NG_009820.2:g.5884dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033100.1" sequenceAccession="NG_033100" sequenceVersion="1" change="g.39149dup">
            <Expression>NG_033100.1:g.39149dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041782.1" sequenceAccession="NG_041782" sequenceVersion="1" change="g.25004dup">
            <Expression>NG_041782.1:g.25004dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153405.1" sequenceAccession="NR_153405" sequenceVersion="1" change="n.3367dup">
            <Expression>NR_153405.1:n.3367dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007248.5" sequenceAccession="NM_007248" sequenceVersion="5" change="c.28dup">
            <Expression>NM_007248.5:c.28dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009179.2" sequenceAccession="NP_009179" sequenceVersion="2" change="p.Glu10fs">
            <Expression>NP_009179.2:p.Glu10fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.6" sequenceAccession="NM_033629" sequenceVersion="6" change="c.58dup" MANESelect="true">
            <Expression>NM_033629.6:c.58dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_338599.1" sequenceAccession="NP_338599" sequenceVersion="1" change="p.Glu20fs">
            <Expression>NP_338599.1:p.Glu20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271023.2" sequenceAccession="NM_001271023" sequenceVersion="2" change="c.*1159dup">
            <Expression>NM_001271023.2:c.*1159dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032166.4" sequenceAccession="NM_032166" sequenceVersion="4" change="c.*1159dup">
            <Expression>NM_032166.4:c.*1159dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130384.3" sequenceAccession="NM_130384" sequenceVersion="3" change="c.*1159dup" MANESelect="true">
            <Expression>NM_130384.3:c.*1159dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="AF319569.1" sequenceAccession="AF319569" sequenceVersion="1" change="c.58_59insG">
            <Expression>AF319569.1:c.58_59insG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_282" sequenceAccession="LRG_282">
            <Expression>LRG_282:g.5884dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_282t1" sequenceAccession="LRG_282t1">
            <Expression>LRG_282t1:c.58dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_282p1" sequenceAccession="LRG_282p1" change="p.Glu20fs">
            <Expression>LRG_282p1:p.Glu20fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007248.5" sequenceAccession="NM_007248" sequenceVersion="5" change="c.26_27insG">
            <Expression>NM_007248.5:c.26_27insG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.4" sequenceAccession="NM_033629" sequenceVersion="4" change="c.58dupG">
            <Expression>NM_033629.4:c.58dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA345481" DB="ClinGen" />
        <XRef Type="rs" ID="78300695" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033629.6(TREX1):c.58dup (p.Glu20fs) AND Aicardi-Goutieres syndrome 1" Accession="RCV000114330" Version="8">
        <ClassifiedConditionList TraitSetID="1148">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.58dup (p.Glu20fs) AND multiple conditions" Accession="RCV001384732" Version="3">
        <ClassifiedConditionList TraitSetID="12753">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024145">Chilblain lupus 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1860518">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.58dup (p.Glu20fs) AND TREX1-related disorder" Accession="RCV001731376" Version="3">
        <ClassifiedConditionList TraitSetID="33696">
          <ClassifiedCondition DB="MedGen" ID="CN239414">TREX1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.58dup (p.Glu20fs) AND not provided" Accession="RCV003137626" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-30" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2015-03-24" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16845398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25604658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26938784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29453417</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301648</ID>
          <ID Source="BookShelf">NBK1475</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12753" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6104" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Vasculopathy, retinal, with cerebral leukodystrophy</ElementValue>
                <XRef ID="Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ElementValue>
                <XRef ID="MONDO:0008641" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal vasculopathy, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RVCLS</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRV</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RVCL</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.</Attribute>
                <XRef ID="NBK546576" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TREX1-Related Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1217" />
                <XRef ID="1217" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536185</ID>
                <ID Source="BookShelf">NBK546576</ID>
              </Citation>
              <XRef ID="247691" DB="Orphanet" />
              <XRef ID="3421" DB="Orphanet" />
              <XRef ID="63261" DB="Orphanet" />
              <XRef ID="71291" DB="Orphanet" />
              <XRef ID="C1860518" DB="MedGen" />
              <XRef ID="MONDO:0008641" DB="MONDO" />
              <XRef Type="MIM" ID="192315" DB="OMIM" />
            </Trait>
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15167" />
                <XRef ID="15167" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
            <Trait ID="1425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chilblain lupus 1</ElementValue>
                <XRef ID="MONDO:0012500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHBL1</ElementValue>
                <XRef Type="MIM" ID="610448" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18493" />
                <XRef ID="18493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0024145" DB="MedGen" />
              <XRef ID="MONDO:0012500" DB="MONDO" />
              <XRef Type="MIM" ID="610448" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1148" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15167" />
                <XRef ID="15167" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33696" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36611" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TREX1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TREX1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">TREX1-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239414" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3891745" SubmissionDate="2021-11-02" DateLastUpdated="2021-11-06" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="SUB10606393" submittedAssembly="GRCh38" title="SUB10606393" />
        <ClinVarAccession Accession="SCV001994861" DateUpdated="2021-11-06" DateCreated="2021-11-06" Type="SCV" Version="1" SubmitterName="Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences" OrgID="505943" OrganizationCategory="other" OrgAbbreviation="SGPGIMS" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian</Ethnicity>
              <GeographicOrigin>North India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001276" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000378" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000496" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011499" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000364" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000308" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002514" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002135" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1">
              <Name>three prime repair exonuclease 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NG_009820.2:g.5884dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225750" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606393</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878923" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_007248.3:c.28dup|TREX1-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984797" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshift variant is found in the only exon of TREX1, and frameshift variants located downstream of this variant have been reported as disease-causing variants in the Human Gene Mutation Database (PMID: 24183309, 20301648). This variant has been previously reported as a compound heterozygous and a homozygous change in patients with Aicardi-Goutieres syndrome (PMID: 16845398, 26182405, 28832562, 29453417). It is present in the heterozygous state in the gnomAD population database at a frequency of .013% (32/251392) and thus is presumed to be rare. Based on the available evidence, the c.28dup (p.Glu10GlyfsTer82) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007248.3:c.28dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TREX1-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10524990</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110011" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="2343848|MedGen:C1860518;C0796126;C0024145" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584366" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16845398</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25604658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16845398</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25604658</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu20Glyfs*82) in the TREX1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 295 amino acid(s) of the TREX1 protein. This variant is present in population databases (rs748398051, gnomAD 0.1%). This premature translational stop signal has been observed in individual(s) with autosomal recessive Aicardi-Goutieres syndrome and neurological features (PMID: 16845398, 25604658). This variant is also known as 58_59insG (E20fs). ClinVar contains an entry for this variant (Variation ID: 126390). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the TREX1 protein in which other variant(s) (p.Arg164*) have been determined to be pathogenic (PMID: 16845398, 25604658). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48508110_48508111insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1860518" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796126" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024145" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8808814" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="2082166|TREX1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004725028" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The TREX1 c.58dupG variant is predicted to result in a frameshift and premature protein termination (p.Glu20Glyfs*82). This variant (aka c.223dup, p.Glu75Glyfs*82) has been reported in the homozygous or compound heterozygous states in multiple individuals with Aicardi-Goutières syndrome (Crow et al. 2006. PubMed ID: 16845398; Crow et al. 2015. PubMed ID: 25604658. Table S1; Lim et al. 2015. PubMed ID: 26182405. Supplementary file 1; Dillon et al. 2018. PubMed ID: 29453417. Table S1). This variant is reported in 0.10% of alleles in individuals of South Asian descent in gnomAD. Frameshift variants in TREX1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.4:c.58dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TREX1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="267515" SubmissionDate="2014-03-13" DateLastUpdated="2015-03-24" DateCreated="2014-04-19">
        <ClinVarSubmissionID localKey="AF319569.1:c.58_59insG 1|OMIM:225750" />
        <ClinVarAccession Accession="SCV000147897" DateUpdated="2015-03-24" DateCreated="2014-04-19" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-03-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>AAK07616.1:p.Glu20GlyfsTer81</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">AF319569.1:c.58_59insG 1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Aicardi Goutieres syndrome 1</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="225750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GRs_3-13-14</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="947389" SubmissionDate="2016-11-01" DateLastUpdated="2015-03-24" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="NM_016381.4:c.223dupG|OMIM:225750" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000484428" DateUpdated="2015-03-24" DateCreated="2015-03-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26938784</ID>
          </Citation>
          <Comment>This heterozygous duplication variant is predicted to create a substitution of a glutamic acid to a glycine at position 75 and cause a frameshift and premature truncation 82 amino acids downstream, NP_057465.1(TREX1): p.(Glu75Glyfs*82). This change is predicted to be disease-causing by in-silico models and is novel. It was identified in a patient with clinical features of AGS, and a second truncating mutation in trans.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>3</NumberTested>
              <Gender>male</Gender>
              <FamilyData NumFamilies="1" NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <NamePlatform>HiSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Description>Illumina Nextera Exome</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Generalized hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001290" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Cortical gyral simplification</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0009879" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the periventricular white matter</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002518" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Cerebellar hypoplasia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001321" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hypoplasia of the brainstem</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002365" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the medulla oblongata</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011441" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016381.4:c.223dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225750" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">26938784</ID>
        </Citation>
        <StudyDescription>MGHA CS Infant Cohort</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>MGHA_CS_Infant_Cohort</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7332470" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="f641498f-f367-40e9-9727-5101645be045" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922196" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The homozygous p.Glu20GlyfsTer82 variant in TREX1 was identified by our study in one individual with Aicardi Goutieres syndrome. The p.Glu20GlyfsTer82 variant in TREX1 has been previously reported in 12 unrelated individuals with Aicardi Goutieres syndrome 1 (PMID: 26938784, PMID: 33235754, PMID: 25604658, PMID: 16845398) but has been identified in 0.1% (32/30616) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs770193197). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of these 12 previously reported unrelated individuals (PMID: 26938784, PMID: 33235754, PMID: 25604658, PMID: 16845398), 7 were homozygotes (PMID: 16845398, PMID: 25604658), 1 was a compound heterozygote who carried a likely pathogenic variant in trans (PMID: 26938784, ClinVar ID: 369666), and 2 were compound heterozygotes who carried pathogenic or likely pathogenic variants in unknown phase (PMID: 33235754, ClinVar Variation ID: 126384, 126392), which increases the likelihood that the p.Glu20GlyfsTer82 variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 126390) and has been interpreted as pathogenic by Invitae, Rady Children's Institute for Genomic Medicine, Murdoch Childrens Research Institute Victorian Clinical Genetics Services, GeneReviews, and Sanjay Gandhi Post Graduate Institute of Medical Sciences Department of Medical Genetics. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 20 and leads to a premature termination codon 82 amino acids downstream. This termination codon occurs within the last exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. Loss of function of the TREX1 gene is an established disease mechanism in autosomal recessive Aicardi Goutieres syndrome 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Aicardi Goutieres syndrome 1. ACMG/AMP Criteria applied: PVS1_Strong, PM3_Strong (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_033629.6(TREX1):c.58dup</Name>
            <Name>p.Glu20fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.12:g.48466713dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009165" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7336410" SubmissionDate="2023-05-15" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="SUB13342985" submittedAssembly="hg19" title="SUB13342985" />
        <ClinVarAccession Accession="SCV003924379" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">29453417</ID>
          </Citation>
          <Comment>A Homozygote Frameshift variant c.26_27insG in Exon 2 of the TREX1 gene that results in the amino acid substitution p.Glu10fs*82 was identified. The observed variant has a minor allele frequency of 0.00013% in gnomAD exomes and novel in gnomAD genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic [Variation ID: 126390]. The observed variant has been previously reported as a compound heterozygous and a homozygous mutation in patients with Aicardi-Goutieres syndrome (Dillon OJ, et.al., 2018). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1">
              <Name>three prime repair exonuclease 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_007248.5:exon 2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs78300695" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007248.5:c.26_27insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225750" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13342985</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7125539" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="9a2c7790b4a1bc0e600991b4ecfd6456370ad061ff5d4f6b43dc6da600543a1c|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003823657" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.6:c.58dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7332470" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009165" MappingRef="MONDO">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Cortical gyral simplification" MappingRef="Preferred">
        <MedGen CUI="C2749675" Name="Simplified gyral pattern" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Hypoplasia of the brainstem" MappingRef="Preferred">
        <MedGen CUI="C1842688" Name="Hypoplasia of the brainstem" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000496" MappingRef="HP">
        <MedGen CUI="C0497202" Name="Abnormality of eye movement" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8808814" TraitType="Disease" MappingType="Name" MappingValue="TREX1-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239414" Name="TREX1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Disease" MappingType="XRef" MappingValue="225750" MappingRef="OMIM">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002135" MappingRef="HP">
        <MedGen CUI="C1389280" Name="Basal ganglia calcification" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7125539" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110011" TraitType="Disease" MappingType="XRef" MappingValue="C0796126" MappingRef="MedGen">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001276" MappingRef="HP">
        <MedGen CUI="C0026826" Name="Hypertonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="267515" TraitType="Disease" MappingType="Name" MappingValue="Aicardi Goutieres syndrome 1" MappingRef="Preferred">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011499" MappingRef="HP">
        <MedGen CUI="C0026961" Name="Mydriasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336410" TraitType="Disease" MappingType="XRef" MappingValue="225750" MappingRef="OMIM">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the medulla oblongata" MappingRef="Preferred">
        <MedGen CUI="C4021148" Name="Abnormal medulla oblongata morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002514" MappingRef="HP">
        <MedGen CUI="C0270685" Name="Cerebral calcification" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Cerebellar hypoplasia" MappingRef="Preferred">
        <MedGen CUI="C0266470" Name="Cerebellar hypoplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110011" TraitType="Disease" MappingType="XRef" MappingValue="C1860518" MappingRef="MedGen">
        <MedGen CUI="C1860518" Name="Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Generalized hypotonia" MappingRef="Preferred">
        <MedGen CUI="C1858120" Name="Generalized hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000364" MappingRef="HP">
        <MedGen CUI="C4025860" Name="Hearing abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878923" TraitType="Disease" MappingType="Name" MappingValue="TREX1-related disorders" MappingRef="Preferred">
        <MedGen CUI="CN239414" Name="TREX1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000252" MappingRef="HP">
        <MedGen CUI="C4551563" Name="Microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Disease" MappingType="XRef" MappingValue="225750" MappingRef="OMIM">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000308" MappingRef="HP">
        <MedGen CUI="C1839546" Name="Microretrognathia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="947389" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the periventricular white matter" MappingRef="Preferred">
        <MedGen CUI="C2673431" Name="Abnormal periventricular white matter morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110011" TraitType="Disease" MappingType="XRef" MappingValue="C0024145" MappingRef="MedGen">
        <MedGen CUI="C0024145" Name="Chilblain lupus 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3891745" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000378" MappingRef="HP">
        <MedGen CUI="C1845447" Name="Cupped ear" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

